175 related articles for article (PubMed ID: 25457818)
41. Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson's Disease Dementia.
Kim Y; Lee D; Cho KH; Lee JJ; Ham JH; Ye BS; Lee SK; Lee JM; Sohn YH; Lee PH
J Alzheimers Dis; 2017; 55(2):485-495. PubMed ID: 27662310
[TBL] [Abstract][Full Text] [Related]
42. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease.
Filoteo JV; Reed JD; Litvan I; Harrington DL
Mov Disord; 2014 Mar; 29(3):360-7. PubMed ID: 24038502
[TBL] [Abstract][Full Text] [Related]
43. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
44. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
[TBL] [Abstract][Full Text] [Related]
45. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
[TBL] [Abstract][Full Text] [Related]
46. Changes on brief cognitive instruments over time in Parkinson's disease.
Lessig S; Nie D; Xu R; Corey-Bloom J
Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
[TBL] [Abstract][Full Text] [Related]
47. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
[TBL] [Abstract][Full Text] [Related]
48. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities.
Biundo R; Formento-Dojot P; Facchini S; Vallelunga A; Ghezzo L; Foscolo L; Meneghello F; Antonini A
J Neurol Sci; 2011 Nov; 310(1-2):64-9. PubMed ID: 21862438
[TBL] [Abstract][Full Text] [Related]
49. Cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Kulisevsky J
Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
[TBL] [Abstract][Full Text] [Related]
50. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
[TBL] [Abstract][Full Text] [Related]
51. Parietal Involvement in Constructional Apraxia as Measured Using the Pentagon Copying Task.
Van der Stigchel S; de Bresser J; Heinen R; Koek HL; Reijmer YD; Biessels GJ; van den Berg E;
Dement Geriatr Cogn Disord; 2018; 46(1-2):50-59. PubMed ID: 30145597
[TBL] [Abstract][Full Text] [Related]
52. Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.
Carriere N; Besson P; Dujardin K; Duhamel A; Defebvre L; Delmaire C; Devos D
Mov Disord; 2014 Jun; 29(7):897-903. PubMed ID: 24817690
[TBL] [Abstract][Full Text] [Related]
53. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
[TBL] [Abstract][Full Text] [Related]
54. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
55. Gray matter correlations of cognition in incident Parkinson's disease.
Dalaker TO; Zivadinov R; Larsen JP; Beyer MK; Cox JL; Alves G; Bronnick K; Tysnes OB; Antulov R; Dwyer MG; Aarsland D
Mov Disord; 2010 Apr; 25(5):629-33. PubMed ID: 20213820
[TBL] [Abstract][Full Text] [Related]
56. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
Jokinen P; Brück A; Aalto S; Forsback S; Parkkola R; Rinne JO
Parkinsonism Relat Disord; 2009 Feb; 15(2):88-93. PubMed ID: 18434233
[TBL] [Abstract][Full Text] [Related]
57. Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease.
Yadav SK; Kathiresan N; Mohan S; Vasileiou G; Singh A; Kaura D; Melhem ER; Gupta RK; Wang E; Marincola FM; Borthakur A; Haris M
J Neurol; 2016 Nov; 263(11):2308-2318. PubMed ID: 27544505
[TBL] [Abstract][Full Text] [Related]
58. Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).
Sánchez-Ferro Á; Benito-León J; Mitchell AJ; Louis ED; Posada IJ; Trincado R; Villarejo A; Bermejo-Pareja F
J Neurol Sci; 2011 Nov; 310(1-2):211-5. PubMed ID: 21621225
[TBL] [Abstract][Full Text] [Related]
59. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
[TBL] [Abstract][Full Text] [Related]
60. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
